Why is Biogen Pharma falling/rising?

As of 15-Oct, Biogen Pharmachem Industries Ltd is experiencing a decline in its stock price, currently at 0.83, which reflects a decrease of 0.01 or 1.19%. The stock has underperformed its sector by 2.96% today and has been on a consecutive downward trend for the last three days, resulting in a total decline of 4.6% during this period. Additionally, the stock is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bearish trend. The stock has also shown significant underperformance over various time frames, with a year-to-date decline of 29.66% compared to a 5.72% increase in the benchmark index, Sensex. Unfortunately, there is no information available regarding positive or negative factors that could influence the stock's recent movement.
Broader Market Context: In the short term, Biogen Pharma's performance has been notably weaker than the benchmark, as it has declined by 3.49% over the past week while the Sensex has increased by 1.02%. This stark contrast highlights the stock's struggles in a generally positive market environment. The falling investor participation, evidenced by a 9.74% drop in delivery volume against the 5-day average, further suggests a lack of confidence among investors, contributing to the stock's downward trajectory. Overall, the combination of poor performance metrics and negative investor sentiment indicates that Biogen Pharma is facing significant challenges in the current market landscape.